BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9589074)

  • 1. Albocycline- and carbomycin-type macrolides, inhibitors of human prolyl endopeptidases.
    Christner C; Küllertz G; Fischer G; Zerlin M; Grabley S; Thiericke R; Taddei A; Zeeck A
    J Antibiot (Tokyo); 1998 Mar; 51(3):368-71. PubMed ID: 9589074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolyl endopeptidase inhibitors].
    Aoyagi T; Muraoka Y
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1971-86. PubMed ID: 8210438
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
    Konaklieva MI; Plotkin BJ
    Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases.
    Vendeville S; Goossens F; Debreu-Fontaine MA; Landry V; Davioud-Charvet E; Grellier P; Scharpe S; Sergheraert C
    Bioorg Med Chem; 2002 Jun; 10(6):1719-29. PubMed ID: 11937331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening, isolation and structure elucidation.
    Heinze S; Ritzau M; Ihn W; Hülsmann H; Schlegel B; Dornberger K; Fleck WF; Zerlin M; Christner C; Gräfe U; Küllertz G; Fischer G
    J Antibiot (Tokyo); 1997 May; 50(5):379-83. PubMed ID: 9207906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propeptin, a new inhibitor of prolyl endopeptidase produced by Microbispora. I. Fermentation, isolation and biological properties.
    Kimura K; Kanou F; Takahashi H; Esumi Y; Uramoto M; Yoshihama M
    J Antibiot (Tokyo); 1997 May; 50(5):373-8. PubMed ID: 9207905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of prolyl endopeptidase inhibitors and evaluation of their structure-activity relationships: in vitro inhibition of prolyl endopeptidase from canine brain.
    Arai H; Nishioka H; Niwa S; Yamanaka T; Tanaka Y; Yoshinaga K; Kobayashi N; Miura N; Ikeda Y
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1583-8. PubMed ID: 8221972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of penem inhibitors of bacterial signal peptidase.
    Harris DA; Powers ME; Romesberg FE
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3787-90. PubMed ID: 19427205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular modeling studies of prolyl endopeptidase inhibitors].
    Kánai K; Fehér M; Lopata A; Podányi B; Novák I; Susán E; Hermecz I; Arányi P
    Acta Pharm Hung; 1999 Nov; 69(5):240-6. PubMed ID: 10652791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XXIV. Effect of mikamycin, carbomycin, spiramycin, erythromycin, and paromomycin on growth and respiration of HeLa cells.
    Dixon H; Kellerman GM; Linnane AW
    Arch Biochem Biophys; 1972 Oct; 152(2):869-75. PubMed ID: 4635794
    [No Abstract]   [Full Text] [Related]  

  • 11. Propeptin, a new inhibitor of prolyl endopeptidase produced by microbispora II. Determination of chemical structure.
    Esumi Y; Suzuki Y; Itoh Y; Uramoto M; Kimura K; Goto M; Yoshihama M; Ichikawa T
    J Antibiot (Tokyo); 2002 Mar; 55(3):296-300. PubMed ID: 12014445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolases.
    Camara K; Kamat SS; Lasota CC; Cravatt BF; Howell AR
    Bioorg Med Chem Lett; 2015 Jan; 25(2):317-21. PubMed ID: 25541002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of bacterial signal peptidases.
    Black MT; Bruton G
    Curr Pharm Des; 1998 Apr; 4(2):133-54. PubMed ID: 10197037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poststatin, a new inhibitor of prolyl endopeptidase. VII. N-cycloalkylamide analogues.
    Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1996 Sep; 49(9):909-20. PubMed ID: 8931725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.
    Jarho EM; Venäläinen JI; Huuskonen J; Christiaans JA; Garcia-Horsman JA; Forsberg MM; Järvinen T; Gynther J; Männistö PT; Wallén EA
    J Med Chem; 2004 Nov; 47(23):5605-7. PubMed ID: 15509157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 18. SNA-8073-B, a new isotetracenone antibiotic inhibits prolyl endopeptidase. I. Fermentation, isolation and biological properties.
    Kimura K; Kanou F; Koshino H; Uramoto M; Yoshihama M
    J Antibiot (Tokyo); 1997 Apr; 50(4):291-6. PubMed ID: 9186552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel inhibitors against the bacterial signal peptidase I].
    Liao GJ; He Y; Xie JP
    Yao Xue Xue Bao; 2012 Dec; 47(12):1561-6. PubMed ID: 23460958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of interaction of cysteine proteinases and their protein inhibitors as compared to the serine proteinase-inhibitor interaction.
    Bode W; Engh R; Musil D; Laber B; Stubbs M; Huber R; Turk V
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():111-8. PubMed ID: 2205234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.